Fitell Corp Trading Halted, News Pending
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 08 2026
0mins
Fitell Corp trading halted, news pending
Get Free Real-Time Notifications for Any Stock
Monitor tickers like FTEL with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on FTEL
About FTEL
Fitell Corporation, through GD Wellness Pty Ltd, its wholly owned subsidiary, is an online retailer of gym and fitness equipment both under its brands and other brand names in Australia. The Company’s brand portfolio is categorized into three brands under its Gym Direct brand: Muscle Motion, Rapid Motion, and FleetX, in over 2,000 stock-keeping units (SKUs). The Company’s products and services include fitness equipment and licensing business. It markets and sells fitness equipment and related products as well as a shop for business setup from personal training studios to commercial gyms. Its fitness equipment products are sold directly to customers through online or offline platforms. Its licensing business offers turnkey solution for personal training studios and commercial gym chains. Its artificial intelligence (AI)-powered interactive platform, 1FinalRound, provides online training content along with various other services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Cyclerion Therapeutics Expands Collaboration with Medsteer, Shares Surge 44.2%
- Significant Stock Surge: Cyclerion Therapeutics shares rose 44.2% to $1.99 in pre-market trading, reflecting strong market confidence in the company's expanded strategic collaboration with Medsteer, indicating positive investor sentiment towards future growth prospects.
- Deepening Strategic Collaboration: The partnership with Medsteer aims to advance the closed-loop anesthetic platform CYC-126, which is expected to accelerate the product's market entry, thereby enhancing the company's competitive edge in the anesthesia sector.
- Optimistic Market Outlook: With continuous advancements in anesthetic technology, Cyclerion's new platform is poised to meet the increasing medical demand, further driving revenue growth and strengthening its position in the healthcare industry.
- Increased Investor Confidence: The substantial stock price increase not only reflects market approval of the company's strategic direction but may also attract more investor interest, thereby supporting future financing and expansion efforts.
Continue Reading
Fitell Corporation Implements 1-for-8 Share Consolidation to Optimize Capital Structure
- Share Consolidation Plan: Fitell Corporation will implement a 1-for-8 share consolidation on January 8, 2026, reducing outstanding Class A shares from 9,666,791 to 1,208,349 and Class B shares from 402,500 to 201,250, thereby optimizing its capital structure to support future growth.
- Market Trading Arrangement: Post-consolidation, Class A shares will continue trading on Nasdaq under the new CUSIP number G35150146, ensuring a seamless transition for investors at market open and enhancing market liquidity.
- Shareholder Approval and Decision: The share consolidation was approved at the shareholders' extraordinary general meeting on December 12, 2025, with the board confirming the consolidation ratio via written resolutions on December 16, demonstrating transparency and efficiency in corporate governance.
- Future Strategic Positioning: CEO Sam Lu stated that the strengthened equity profile will provide greater flexibility for future strategic partnerships, acquisitions, or other capital market activities, enhancing the company's competitive position within the industry.
Continue Reading